Methods of inhibiting tumor metastasis

Thromboxane A2 receptor antagonists, such as ifetroban, inhibit solid tumor metastasis. The formation of surface and microscopic lung metastases are inhibited. Thromboxane A2 receptor antagonists can inhibit the tumor metastasis process without affecting the growth or development of a primary tumor.

Saved in:
Bibliographic Details
Main Authors PULLEY, JILL M, LAVIERI, ROBERT R
Format Patent
LanguageChinese
English
Published 01.07.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Thromboxane A2 receptor antagonists, such as ifetroban, inhibit solid tumor metastasis. The formation of surface and microscopic lung metastases are inhibited. Thromboxane A2 receptor antagonists can inhibit the tumor metastasis process without affecting the growth or development of a primary tumor.
Bibliography:Application Number: TW20187142806